Tony Wied
Suspicious Timing Detected
5 flagsTony Wied bought $1,001 - $15,000 in $LRCX on 2026-02-09 — 1 day before the "Taiwan Energy Security and Anti-Embargo Act of 2026" (S2722) advanced to the Senate Legislative Calendar, which could indicate increased momentum for U.S. semiconductor manufacturing.
Tony Wied bought $1,001 - $15,000 in $LRCX on 2026-02-03 — 7 days before the "Taiwan Energy Security and Anti-Embargo Act of 2026" (S2722) advanced to the Senate Legislative Calendar, which could indicate increased momentum for U.S. semiconductor manufacturing.
Tony Wied bought $1,001 - $15,000 in $LH on 2026-02-19 — 13 days before HR7787, a bill to strengthen the mental health workforce, was introduced. This bill establishes a mental health provider loan deferment and forgiveness program.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Date |
|---|---|---|---|---|
| BUY | $FTNT | Fortinet Inc | $1K-$15K | Feb 19, 2026 |
| BUY | $V | Visa Inc Class A | $1K-$15K | Feb 19, 2026 |
| BUY | $LH | Labcorp Holdings Inc | $1K-$15K | Feb 19, 2026 |
| BUY | $SCHW | Charles Schwab Corp | $1K-$15K | Feb 19, 2026 |
| BUY | $MU | Micron Technology Inc | $1K-$15K | Feb 19, 2026 |
| BUY | $AVGO | Broadcom Inc | $1K-$15K | Feb 19, 2026 |
| BUY | $WAL | Western Alliance Bancorp | $1K-$15K | Feb 19, 2026 |
| BUY | $CRM | Salesforce Inc | $1K-$15K | Feb 17, 2026 |
| BUY | Treasury Bill | US Treasury Bill26U ST Bill Due 5/14/26(Treasury Bill) | $1K-$15K | Feb 13, 2026 |
| BUY | $LRCX | Lam Resh Corp | $1K-$15K | Feb 12, 2026 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Medical Nutrition Therapy Act of 2026
The Medical Nutrition Therapy Act of 2026 structurally expands Medicare Part B to cover nutrition counseling for obesity, cancer, HIV/AIDS, and eating disorders — a direct benefit expansion for MA insurers Humana, UnitedHealth, Centene, and CVS Health, which can integrate these services to manage chronic disease costs. The bill is early-stage (referred to Senate Finance, 2 co-sponsors), but real market data shows the affected tickers have experienced 19-70% 30-day gains, reflecting broader sector momentum.
A bill to support National Science Foundation education and professional development relating to artificial intelligence.
S.3957 (NSF AI Education Act of 2026) is an early-stage bill authorizing NSF to create AI education programs but provides zero direct funding or procurement mandates. With only two sponsors, a single referral to committee, and no appropriations, its near-term market impact is negligible. NVDA remains driven by real earnings and private capex, not procedural authorization bills.
To amend the Financial Stability Act of 2010 to apply the enhanced supervision and prudential standards applicable under such Act with respect to bank holding companies to large banks that do not have a bank holding company, and for other purposes.
HR7888 (Closing the Enhanced Prudential Standards Loophole Act) is in early-stage legislative process, having been introduced and referred to committee on March 9, 2026. The bill would extend enhanced regulatory oversight currently applicable to large bank holding companies to large banks without a holding company, increasing compliance costs for affected institutions. No market impact is expected in the near term as the bill remains in early stages with a full legislative path ahead.
TRUST Act of 2026
The TRUST Act of 2026 is an early-stage bill that would reduce examination frequency from 12 to 18 months for qualifying banks under $6B in assets. None of the tracked regional bank tickers ($WAL, $ZION, $FCNCA, $EWBC) qualify—they all exceed the threshold. No direct market impact from this legislation exists; recent price movements are driven by sector dynamics.
Enhanced Cybersecurity for SNAP Act of 2026
The Enhanced Cybersecurity for SNAP Act mandates chip-enabled and mobile-friendly EBT cards, creating a forced contract upgrade cycle for payment processors FIS and GPN. The bill is early-stage with no appropriated funding, but the mandate structure ensures state-level spending on compliance. Current market prices for FIS at $46.25 and GPN at $71.42 offer potential entry points ahead of legislative momentum, with both stocks trading well below their 52-week highs.
Taiwan Energy Security and Anti-Embargo Act of 2026
The Taiwan Energy Security and Anti-Embargo Act of 2026 has advanced to the Senate Legislative Calendar with active bipartisan sponsorship, directly benefiting U.S. LNG exporters and midstream operators through statutory preference for Taiwan-linked LNG exports. Real market data confirms $LNG up 5.85% and $ET up 3.19% over the past 7 days, reflecting growing legislative momentum and structural demand from Taiwan's semiconductor sector.
To amend title VII of the Public Health Service Act to strengthen the mental health workforce, and for other purposes.
HR7787 is an early-stage bill authorizing a mental health provider loan forgiveness program. It has been referred to committee with no companion bill, zero appropriations, and minimal legislative momentum. Market impact is negligible at this stage. Real market data shows AMN Healthcare at $20.65, up 12.6% over 30 days, and Centene at $53.22, up 62.55% over 30 days, driven by other factors unrelated to this procedural bill.
To amend the Public Health Service Act with respect to the Living Organ Donation Reimbursement Program.
HR7868, the 'Expanding Support for Living Donors Act of 2026,' is an early-stage bill authorizing up to $10,000 per donor for qualifying expenses in FY2027. Actual appropriations are required. The market reaction in diagnostic ($LH, $DGX) and device ($MDT, $SYK) stocks is currently driven by broader market trends — all four stocks are down 2-9% over the past 30 days — not by this bill's introduction. The legislative impact on revenue is negligible at this stage.
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "The Fair Credit Reporting Act's Limited Preemption of State Laws".
S.J. Res. 129 is a CRA disapproval resolution nullifying the CFPB's withdrawal of FCRA preemption, reimposing a costly 50-state regulatory patchwork for credit reporting. This directly raises operating expenses for Equifax ($EFX) and FICO ($FICO) as compliance costs increase, and pressures national lenders Capital One ($COF) and American Express ($AXP) to adapt uniform credit systems to state-specific regulations. The bill is on the Senate calendar with fast-track CRA rules, making floor action imminent.
Protect Liberty and End Warrantless Surveillance Act of 2026
HR7816 is an early-stage bill restricting warrantless commercial data acquisition by intelligence agencies. It poses marginal negative risk to third-party threat intelligence feeds, but cybersecurity companies' core revenues depend on proprietary endpoint/network telemetry, not purchased data. The bill faces a long legislative path with low passage probability in current form. Market data shows cybersecurity stocks with strong 30-day gains (CRWD +13.7%, PANW +11.0%, S +10.6%) despite a slight pullback in the last 7 days.
Other Filings by Tony Wied
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.